Skip to content
Screener

Common Stock at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
265M0.0%
IQVIA logo
IQVIAIQV
400M0.0%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
265M0.0%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$11K+57.1%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$38K
NeoGenomics logo
NeoGenomicsNEO
$130K+1.6%

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.41B+35.7%
Enterprise value$16.05B+31.6%
P/E33.4×+4.5×
P/S5.9×+0.5×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
(Amounts in thousands, except share amounts)As of / June 30,2026As of / December 31,2025
Commitments and contingencies (see Note 11)
Shareholders’ equity:
Preferred stock - $0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025
Common stock - $0.01 par-value; 250,000,000 shares authorized at June 30, 2026 and December 31, 2025; 27,910,605 and 28,370,780 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively279284
Treasury stock - 69,593 and 69,623 shares at June 30, 2026 and December 31, 2025, respectively(12,151)(12,156)
Additional paid-in capital964,183935,830
Accumulated deficit(511,368)(459,981)
Accumulated other comprehensive loss(7,082)(4,906)

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s common stock?
Medpace Holdings, Inc. (MEDP) reported common stock of 250M in Q2 2026.
How has Medpace Holdings, Inc.'s common stock changed year-over-year?
Medpace Holdings, Inc.'s common stock decreased by 0.0% year-over-year, from 250M to 250M.
What is the long-term trend for Medpace Holdings, Inc.'s common stock?
Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s common stock has grown at a 271.1% compound annual growth rate (CAGR), from 355K to 250M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Medpace Holdings, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude